GENESIS-PHARMA
1.3.2024 09:38:30 CET | Business Wire | Press release
GENESIS Pharma, a regional biopharma company specialized in the commercialization of innovative medicines targeting severe and rare diseases in Central and Eastern Europe, announces an exclusive distribution agreement for the cancer medicine cemiplimab in Greece, Cyprus and Malta with Regeneron Ireland DAC. Regeneron Ireland DAC is a wholly owned subsidiary of Regeneron, a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases.
Cemiplimab is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells and was invented using Regeneron's proprietary VelocImmune® technology. In the European Union, cemiplimab is indicated for adults as monotherapy treatment for certain patients with locally advanced or metastatic basal cell carcinoma (BCC), as monotherapy treatment for certain patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC), as both monotherapy or in combination with chemotherapy for certain patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) and as monotherapy treatment for certain patients with recurrent or metastatic cervical cancer.
The two companies will work to seamlessly complete the transition of all relevant commercialization activities by the second quarter of 2024.
Mr. Constantinos Evripides, Managing Director of GENESIS Pharma stated: “For more than 20 years our company has been committed to ensure patient access to innovative therapies for serious diseases in several European markets building upon a constantly growing network of partners that includes leading global biopharma companies. It is thus our honor to initiate a new agreement with Regeneron, a pioneering company committed to cutting-edge science, that further enhances our long-term expertise and focus on medicines targeting difficult-to-treat cancers.”
About GENESIS Pharma: GENESIS Pharma is a regional biopharma company focused on the commercialization of innovative biopharmaceutical products targeting severe and rare diseases in Central and Eastern Europe. Established in 1997, GENESIS Pharma was among the first pharmaceutical companies in Europe to specialize in the marketing, sales and distribution of biopharmaceutical products. GENESIS Pharma maintains a strong portfolio in therapeutic areas with high unmet medical need through long standing strategic alliances with some of the leading global biopharma companies.
For more information, please visit www.genesispharmagroup.com or follow GENESIS Pharma on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240301136761/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Amazfit Introduces T-Rex Dual Solar, the First AMOLED Smartwatch with Dual-Sided Solar Charging22.9.2026 13:00:00 CEST | Press release
Built for adventures beyond the grid, T-Rex Dual Solar combines a bright AMOLED display with dual-sided solar energy recovery designed to extend battery life when access to traditional power is limited. Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the T-Rex Dual Solar, a premium expedition smartwatch built for long-distance and multi-day exploration. Launching on the autumnal equinox — a day defined by the balance of sunlight and darkness — the T-Rex Dual Solar is the world’s first AMOLED smartwatch featuring a dual-sided solar charging system, combining solar collection either through the display or through an innovative glass ceramic back plate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922588618/en/ The Amazfit T-Rex Dual Solar is the world’s first AMOLED smartwatch featuring a dual-sided solar charging system, combining solar collection either through the display or through
Saildrone USVs Receive Danish Flag Registration for European Operations22.9.2026 12:45:00 CEST | Press release
Saildrone today announced that the first four Saildrone Voyager USVs (unmanned surface vehicles) have been registered in Denmark and will operate under the Danish flag, marking the first time Saildrone USVs will operate under a national flag. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922488140/en/ A Saildrone Voyager operates in the Baltic Sea in support of maritime domain awareness missions. The 10-meter USV is one of the first Saildrone platforms registered in Denmark to operate under the Danish flag. The registration establishes a clear flag-state framework for Saildrone USVs operating internationally. Working together, Saildrone and the Danish Maritime Authority developed the regulatory framework necessary to register and operate unmanned surface vehicles under the Danish flag. “We are pleased that Saildrone has chosen Denmark as the flag state for the company’s uncrewed vessels. This underscores that Denmark, as
NIQ Announces Friendly Bid to Acquire The U Group & Co Limited, Expanding Trusted Intelligence for the AI Era22.9.2026 12:45:00 CEST | Press release
NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced that its wholly-owned Australian subsidiary, Nielsen Connect Australia Pty Ltd (NIQ Australia) has launched a conditional off-market offer for all outstanding shares of The U Group & Co Limited (The U Group) as a friendly takeover bid (Offer). The U Group is an Australian-based company specializing in first-party, consumer-consented purchase data collection through its ReceiptJar app, receipt intelligence, and AI-powered data processing capabilities. In connection with the Offer, NIQ Australia has lodged its Bidder's Statement with the Australian Securities and Investments Commission and dispatched the Offer materials to shareholders of The U Group in accordance with applicable Australian regulatory requirements. The Board of The U Group has unanimously recommended that shareholders accept the Offer for the reasons set out in the Target's Statement. The Offer reflects NIQ's commitment to strengthening trust
OKX Sets a New Standard for Account Protection with OKX Shield22.9.2026 12:30:00 CEST | Press release
Up to €500,000 in account protection for customers in EuropeOKX Shield builds on industry-leading safeguards and advanced account security OKX, a leading global cryptocurrency exchange and onchain technology company with more than 150 million customers worldwide, today launched OKX Shield. OKX Shield is an integrated security product suite combining sophisticated safeguards, visible protection status and the potential for customers to be paid back up to €500,000 following a third-party account-takeover. Account takeover fraud is a challenge for all financial businesses to protect customers against, with billions lost every year in Europe. The most recent EBA and ECB data shows €4.2 billion in payment fraud across Europe in 2024, which was up from €3.5 billion in 2023. Customers are being targeted directly, with attempts to compromise their accounts across financial platforms. OKX Shield brings together account-security enhancements with a new protection program, providing up to €500,00
Infobip Predicts 7.3 Billion Black Friday and Cyber Monday Interactions as AI Reshapes the 2026 Shopping Season22.9.2026 12:26:00 CEST | Press release
New research across nine markets finds 63% of consumers have used AI when shopping, while only 19% plan to wait until Black Friday week to begin their holiday shopping Global AI-first cloud communications platform Infobip predicts more than 7.3 billion customer interactions across Black Friday and Cyber Monday 2026, as AI and conversational channels transform how consumers discover products, receive offers and access support. New Infobip research also reveals that 63.2% of consumers have used an AI assistant or chatbot while shopping during the past 12 months. Black Friday is no longer a single shopping event. Infobip’s research shows that the shopping season now begins weeks earlier and continues through the entire customer journey. Nearly six in ten respondents will have started holiday shopping by early November, while only 19% wait until Black Friday week itself. This extended shopping window is creating new pressure for retailers to engage customers earlier, with better timing, mo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom